Commonwealth Foundation Reviews AI Allegations Against Short Story Prize Winners
The Commonwealth Foundation is reviewing allegations that artificial intelligence was used in entries for its 2026 Short Story Prize. One regional winner, Jamir Nazir of Trinidad and Tobago, is among those under scrutiny after the publisher questioned an AI chatbot about the story.
thesouthafrican.comThe Commonwealth Foundation announced on Friday that it is reviewing allegations that artificial intelligence was used to create entries in this year's Short Story Prize. The review follows questions about a story by regional winner Jamir Nazir of Trinidad and Tobago. " The story remains on the foundation's website. The final overall winner is scheduled to be announced in June.
Granta magazine publisher Sigrid Rausing wrote that the judges may have awarded a prize to an instance of AI plagiarism. She added that AI is the most efficient tool available for detecting AI-generated content. Granta stated it is alarmed by the speculation and noted that its editors were not involved in story selection beyond copy editing.
Farook, director-general of the Commonwealth Foundation, said the organization is taking the allegations seriously. He wrote that a full review will ensure the judging process can address the growing threat AI poses to creativity. Nazir could not be reached for comment.
The foundation did not provide contact information despite repeated requests. The debate follows a similar case earlier this year in which Hachette Book Group canceled a horror novel after AI allegations against its author.
Transparency
Story details
Related Stories
cnbc.comOpenAI Offers U.S. Government Equity Stake in Public AI Wealth Fund
The White House and OpenAI have held talks for more than a year on a potential U.S. equity position. President Trump addressed the concept on Air Force One Friday.
Frontier AI Labs Report Rapid Capability Gains, AI-Written Code; Anthropic Calls for Coordinated Slowdown
Anthropic called for a slowdown or pause among labs developing the most advanced AI systems. The request appeared in a Thursday blog post from its research institute.
EuronewsSmall Phase 1 Safety Trial Tests First AI-Designed Coronavirus Vaccine Candidate
A Phase 1 safety study of an AI-designed protein vaccine against multiple coronaviruses enrolled 39 volunteers and reported no significant safety issues. A Phase 2 trial is now planned.